Tag
- Lonza acquires Roche US biologics facility for $1.2 billion 2024-10-08
- Lonza acquires biologics plant from Roche for $1.2 billion 2024-03-25
- Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug... 2023-12-06
- Aβ monoclonal antibody is broken again, Alzheimer's disease... 2022-11-18
- Roche to Introduce ATR Inhibitor RP-3500 for $1.2 Billion 2022-06-02
- Roche's Next-generation C5 Complement Inhibitor Crovalimab S... 2022-05-24
- Roche's TIGIT Monoclonal Antibody Collapses Again, And A Lar... 2022-05-19
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
- Roche's Potential 'First-in-class' Bispecific Therapy Wins E... 2022-04-24
- Novartis has the most new drugs approved, and Roche's new dr... 2021-08-31
Market Analysis
- Palm Oil Market in December Experiences Volatile Decline Dec-30,2025
- December Cyclohexane Market Operates Weakly, Lacking Momentum for Price Increases Dec-30,2025
- Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025 Dec-30,2025
- December’s Coking Coal Market Primarily Exhibits Weak Performance Dec-30,2025
- This week, the soda ash market in China has been operating weakly Dec-30,2025